Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines
- PMID: 25276075
- PMCID: PMC4166826
- DOI: 10.4103/0974-8490.138291
Anticancer potential of Syzygium aromaticum L. in MCF-7 human breast cancer cell lines
Abstract
Background: The common treatment for cancer is unfavorable because it causes many detrimental side effects, and lately, there has been a growing resistance toward anticancer drugs, which worsens the future of cancer treatment. Therefore, the focus has now shifted toward natural products, such as spices and plants, among many others, to save the future of cancer treatment. Cloves (Syzygium aromaticum L.) are spices with the highest antioxidant content among natural products. Besides acting as an antioxidant, cloves also possess many other functions, such as anti-inflammatory, antibacterial, and antiseptic, which makes them an ideal natural source to be developed as an anticancer agent.
Objective: This study aims to evaluate the cytotoxic activity of cloves toward MCF-7 human breast cancer cell lines.
Materials and methods: Different concentrations of water extract, ethanol extract, and essential oil of cloves were investigated for their anticancer potential in vitro through a brine shrimp lethality test (BSLT) and an MTT assay.
Results: In both BSLT and MTT assays, the essential oil showed the highest cytotoxic effect, followed by ethanol and water extract. The LD50 concentration of essential oil in the 24 hours BSLT was 37 μg/mL. Furthermore, the IC50 values in the 24 hours and 48 hours MTT assays of the essential oil were 36.43 μg/mL and 17.6 μg/mL, respectively.
Conclusion: Cloves are natural products with excellent cytotoxicity toward MCF-7 cells; thus, they are promising sources for the development of anticancer agents.
Keywords: Antioxidant; MCF-7; brine shrimp lethality test; clove; cytotoxicity.
Conflict of interest statement
Figures
Similar articles
-
Anticancer of genus Syzygium: a systematic review.Explor Target Antitumor Ther. 2023;4(2):273-293. doi: 10.37349/etat.2023.00134. Epub 2023 Apr 27. Explor Target Antitumor Ther. 2023. PMID: 37205310 Free PMC article. Review.
-
Clove Flower Extract (Syzygium aromaticum) Has Anticancer Potential Effect Analyzed by Molecular Docking and Brine Shrimp Lethality Test (BSLT).Vet Med Int. 2022 Sep 5;2022:5113742. doi: 10.1155/2022/5113742. eCollection 2022. Vet Med Int. 2022. PMID: 36106174 Free PMC article.
-
Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin.Asian Pac J Cancer Prev. 2011;12(8):1989-93. Asian Pac J Cancer Prev. 2011. PMID: 22292639
-
Extracts of Clove (Syzygium aromaticum) Potentiate FMSP-Nanoparticles Induced Cell Death in MCF-7 Cells.Int J Biomater. 2018 Aug 23;2018:8479439. doi: 10.1155/2018/8479439. eCollection 2018. Int J Biomater. 2018. PMID: 30210543 Free PMC article.
-
The nanocomposites designs of phytomolecules from medicinal and aromatic plants: promising anticancer-antiviral applications.Beni Suef Univ J Basic Appl Sci. 2022;11(1):17. doi: 10.1186/s43088-022-00198-z. Epub 2022 Jan 29. Beni Suef Univ J Basic Appl Sci. 2022. PMID: 35127958 Free PMC article. Review.
Cited by
-
Anti-Proliferative, Analgesic and Anti-Inflammatory Properties of Syzygium mundagam Bark Methanol Extract.Molecules. 2020 Jun 24;25(12):2900. doi: 10.3390/molecules25122900. Molecules. 2020. PMID: 32599705 Free PMC article.
-
Inhibition of Phosphorylated c-Jun NH(2)-terminal Kinase by 2',4'-dihydroxy-6-methoxy-3,5-dimethylchalcone Isolated from Eugenia aquea Burm f. Leaves in Jurkat T-cells.Pharmacogn Mag. 2017 Oct;13(Suppl 3):S573-S577. doi: 10.4103/pm.pm_16_17. Epub 2017 Oct 11. Pharmacogn Mag. 2017. PMID: 29142417 Free PMC article.
-
Anticancer Potential of Syzygium Species: a Review.Plant Foods Hum Nutr. 2019 Mar;74(1):18-27. doi: 10.1007/s11130-018-0704-z. Plant Foods Hum Nutr. 2019. PMID: 30535971 Review.
-
In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis.BMC Complement Med Ther. 2020 Jan 30;20(1):25. doi: 10.1186/s12906-020-2818-8. BMC Complement Med Ther. 2020. PMID: 32020877 Free PMC article.
-
Anticancer of genus Syzygium: a systematic review.Explor Target Antitumor Ther. 2023;4(2):273-293. doi: 10.37349/etat.2023.00134. Epub 2023 Apr 27. Explor Target Antitumor Ther. 2023. PMID: 37205310 Free PMC article. Review.
References
-
- American Cancer Society (ACS) 2nd Edition. Atlanta: American Cancer Society; 2008. [Last cited 2013 Dec 15]. Global Cancer Facts and Figures. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume... .
-
- American Cancer Society (ACS) The Global Cancer Burden. 2011. [Last cited 2013 Dec 20]. Available from http://www.cancer.org/acs/groups/content/@internationalaffairs/docu ment... .
-
- Agency for Toxic Substances and Disease Registry. What Is Cancer. [Last cited 2013 Nov 20]. Available from http://www.atsdr.cdc.gov/COM/cancer.pdf .
-
- Price P, Sikora K, Illidge T. 5th ed. London: Hodder Arnold Publication; 2008. Treatment of Cancer.
-
- Dwivedi V, Shrivastava R, Hussain S, Ganguly C, Bharadwaj M. Comparative anticancer potential of Clove (Syzygium aromaticum) - an Indian spice - against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev. 2011;12:1989–93. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources